Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector.

Li Y, Beitelshees M, Fang L, Hill A, Ahmadi MK, Chen M, Davidson BA, Knight P 3rd, Smith RJ Jr, Andreadis ST, Hakansson AP, Jones CH, Pfeifer BA.

Sci Adv. 2016 Jul 1;2(7):e1600264. doi: 10.1126/sciadv.1600264. eCollection 2016 Jul.

2.

Directed vaccination against pneumococcal disease.

Li Y, Hill A, Beitelshees M, Shao S, Lovell JF, Davidson BA, Knight PR 3rd, Hakansson AP, Pfeifer BA, Jones CH.

Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):6898-903. doi: 10.1073/pnas.1603007113. Epub 2016 Jun 6.

3.

Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccine.

Croney CM, Nahm MH, Juhn SK, Briles DE, Crain MJ.

Clin Vaccine Immunol. 2013 Nov;20(11):1711-8. doi: 10.1128/CVI.00381-13. Epub 2013 Sep 4.

4.

Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.

Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE.

J Immunol. 2012 Dec 1;189(11):5327-35. doi: 10.4049/jimmunol.1201967. Epub 2012 Oct 26.

5.

The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine.

Xin W, Wanda SY, Zhang X, Santander J, Scarpellini G, Ellis K, Alamuri P, Curtiss R 3rd.

Infect Immun. 2012 Oct;80(10):3621-33. doi: 10.1128/IAI.00620-12. Epub 2012 Aug 6.

6.

PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine.

Croney CM, Coats MT, Nahm MH, Briles DE, Crain MJ.

Clin Vaccine Immunol. 2012 Jun;19(6):891-6. doi: 10.1128/CVI.05671-11. Epub 2012 Apr 25.

7.

Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.

Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.

Infect Immun. 2012 Mar;80(3):1166-80. doi: 10.1128/IAI.05511-11. Epub 2011 Dec 12.

8.

Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Norcross EW, Sanders ME, Moore QC 3rd, Taylor SD, Tullos NA, Caston RR, Dixon SN, Nahm MH, Burton RL, Thompson H, McDaniel LS, Marquart ME.

Invest Ophthalmol Vis Sci. 2011 Nov 29;52(12):9232-43. doi: 10.1167/iovs.10-6968.

9.

Monitoring the long-term molecular epidemiology of the pneumococcus and detection of potential 'vaccine escape' strains.

Pandya GA, McEllistrem MC, Venepally P, Holmes MH, Jarrahi B, Sanka R, Liu J, Karamycheva SA, Bai Y, Fleischmann RD, Peterson SN.

PLoS One. 2011 Jan 10;6(1):e15950. doi: 10.1371/journal.pone.0015950.

10.

The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.

Daniels CC, Coan P, King J, Hale J, Benton KA, Briles DE, Hollingshead SK.

Infect Immun. 2010 May;78(5):2163-72. doi: 10.1128/IAI.01199-09. Epub 2010 Mar 1.

11.

Interaction of pneumococcal histidine triad proteins with human complement.

Melin M, Di Paolo E, Tikkanen L, Jarva H, Neyt C, Käyhty H, Meri S, Poolman J, Väkeväinen M.

Infect Immun. 2010 May;78(5):2089-98. doi: 10.1128/IAI.00811-09. Epub 2010 Mar 1.

12.

Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection.

King QO, Lei B, Harmsen AG.

J Infect Dis. 2009 Aug 15;200(4):537-45. doi: 10.1086/600871.

13.

Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.

Melin MM, Hollingshead SK, Briles DE, Lahdenkari MI, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1529-35. doi: 10.1128/CVI.00181-08. Epub 2008 Aug 27.

14.

Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Melin MM, Hollingshead SK, Briles DE, Hanage WP, Lahdenkari M, Kaijalainen T, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1555-63. doi: 10.1128/CVI.00177-08. Epub 2008 Aug 27.

15.

Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis.

Glover DT, Hollingshead SK, Briles DE.

Infect Immun. 2008 Jun;76(6):2767-76. doi: 10.1128/IAI.01126-07. Epub 2008 Apr 7.

16.

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.

Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, Gelbmann D, Lundberg U, Senn BM, Schunn M, Habel A, Henriques-Normark B, Ortqvist A, Kalin M, von Gabain A, Nagy E.

J Exp Med. 2008 Jan 21;205(1):117-31. doi: 10.1084/jem.20071168. Epub 2007 Dec 31.

17.

Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease.

Mahdi LK, Ogunniyi AD, LeMessurier KS, Paton JC.

Infect Immun. 2008 Feb;76(2):646-57. Epub 2007 Nov 26.

18.

Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.

Ochs MM, Bartlett W, Briles DE, Hicks B, Jurkuvenas A, Lau P, Ren B, Millar A.

Microb Pathog. 2008 Mar;44(3):204-14. Epub 2007 Oct 11.

19.

Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.

Darrieux M, Miyaji EN, Ferreira DM, Lopes LM, Lopes AP, Ren B, Briles DE, Hollingshead SK, Leite LC.

Infect Immun. 2007 Dec;75(12):5930-8. Epub 2007 Oct 8.

20.

Distribution and genetic diversity of the ABC transporter lipoproteins PiuA and PiaA within Streptococcus pneumoniae and related streptococci.

Whalan RH, Funnell SG, Bowler LD, Hudson MJ, Robinson A, Dowson CG.

J Bacteriol. 2006 Feb;188(3):1031-8.

Supplemental Content

Support Center